Prolactin and breast cancer

P. M. Schyve; F. Smithline; H. Y. Meltzer

Prolactin and breast cancer

P. M. Schyve, F. Smithline, H. Y. Meltzer

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

No association has been established between increased plasma prolactin levels and breast cancer in man. However, a fraction, perhaps up to 30%, of human breast tumors may be prolactin-dependent. In patients susceptible to or bearing such tumors, the use of prolactin-stimulating antipsychotics may be relatively contraindicatd. Since such persons cannot yet be identified, no changes in current prescribing habits are suggested. As further biologic and epidemiologic data are obtained, however, their implications for clinical practice must be reevaluated.

Original language	English (US)
Pages (from-to)	17-19
Number of pages	3
Journal	Psychopharmacology Bulletin
Volume	14
Issue number	1
State	Published - Jan 1 1978

ASJC Scopus subject areas

Psychiatry and Mental health
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{37de6639d7ac4fe1988d1a9d3c08bb3f,

title = "Prolactin and breast cancer",

abstract = "No association has been established between increased plasma prolactin levels and breast cancer in man. However, a fraction, perhaps up to 30%, of human breast tumors may be prolactin-dependent. In patients susceptible to or bearing such tumors, the use of prolactin-stimulating antipsychotics may be relatively contraindicatd. Since such persons cannot yet be identified, no changes in current prescribing habits are suggested. As further biologic and epidemiologic data are obtained, however, their implications for clinical practice must be reevaluated.",

author = "Schyve, {P. M.} and F. Smithline and Meltzer, {H. Y.}",

year = "1978",

month = jan,

day = "1",

language = "English (US)",

volume = "14",

pages = "17--19",

journal = "Psychopharmacology Bulletin",

issn = "0048-5764",

publisher = "MedWorks Media LLC",

number = "1",

}

TY - JOUR

T1 - Prolactin and breast cancer

AU - Schyve, P. M.

AU - Smithline, F.

AU - Meltzer, H. Y.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - No association has been established between increased plasma prolactin levels and breast cancer in man. However, a fraction, perhaps up to 30%, of human breast tumors may be prolactin-dependent. In patients susceptible to or bearing such tumors, the use of prolactin-stimulating antipsychotics may be relatively contraindicatd. Since such persons cannot yet be identified, no changes in current prescribing habits are suggested. As further biologic and epidemiologic data are obtained, however, their implications for clinical practice must be reevaluated.

AB - No association has been established between increased plasma prolactin levels and breast cancer in man. However, a fraction, perhaps up to 30%, of human breast tumors may be prolactin-dependent. In patients susceptible to or bearing such tumors, the use of prolactin-stimulating antipsychotics may be relatively contraindicatd. Since such persons cannot yet be identified, no changes in current prescribing habits are suggested. As further biologic and epidemiologic data are obtained, however, their implications for clinical practice must be reevaluated.

UR - http://www.scopus.com/inward/record.url?scp=0017804094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017804094&partnerID=8YFLogxK

M3 - Article

C2 - 625530

AN - SCOPUS:0017804094

SN - 0048-5764

VL - 14

SP - 17

EP - 19

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

IS - 1

ER -

Prolactin and breast cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this